| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.0B | $10.9B | $12.1B | $14.0B | $14.2B | $4.2B | $4.4B | $3.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $3.5B | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.7B | $1.9B | $1.9B | $1.9B | $1.9B | $1.8B | $1.9B | $1.2B |
| Operating Income | $-0.8B | $0.6B | $-2.0B | $1.1B | $1.6B | $0.3B | $0.4B | $0.4B |
| Net Income | $-1.3B | $-0.1B | $-2.6B | $0.3B | $1.2B | $-0.5B | $0.3B | $2.4B |
| EPS (Basic) | $-3.26 | $-0.37 | $-6.83 | $0.84 | — | — | $0.61 | — |
| EPS (Diluted) | $-3.26 | $-0.37 | $-6.83 | $0.82 | — | — | $0.61 | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.2B | $11.4B | $12.6B | $16.2B | $17.0B | $17.3B | $17.8B | $24.1B |
| Current Assets | $3.3B | $3.7B | $4.3B | $4.4B | $4.6B | $4.6B | $4.2B | $4.2B |
| Cash & Equivalents | $0.9B | $1.1B | $1.3B | $0.6B | $0.8B | $0.7B | $0.7B | $0.9B |
| Total Liabilities | $10.1B | $10.9B | $12.0B | $13.2B | $13.3B | $12.3B | $12.1B | $14.0B |
| Current Liabilities | $2.7B | $2.6B | $3.1B | $4.2B | $4.7B | $4.0B | $4.0B | $3.4B |
| Stockholders' Equity | $-1.0B | $0.4B | $0.4B | $2.9B | $3.6B | $4.8B | $5.6B | $10.0B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.9B | $0.2B | $1.2B | $2.5B | $1.3B | $1.3B | $1.5B |
| Investing Cash Flow | $-0.2B | $-0.1B | $0.6B | $-0.5B | $-0.2B | $-0.6B | $0.0B | $-0.4B |
| Capital Expenditures | — | — | — | — | — | — | — | $1.0B |
| Financing Cash Flow | $-0.5B | $-1.0B | $-0.1B | $-0.9B | $-2.2B | $-0.7B | $-1.6B | $-1.0B |